Company profile: Nivagen Pharmaceuticals
1.1 - Company Overview
Company description
- Provider of generic prescription drugs and over-the-counter healthcare products for the North American market, engaged in development, acquisition, and sales. Leverages global partnerships with FDA-approved manufacturers to deliver affordable, high-quality products, including Carbamazepine, Celecoxib, Chlorthalidone, and Diclofenac Sodium/Misoprostol.
Products and services
- Generic Prescription Drugs: Nivagen develops, acquires, and delivers a broad range of generics for diverse health conditions in North America, leveraging FDA-approved manufacturing facilities to ensure quality and affordability (FDA-approved)
- Over The Counter Products: Nivagen supplies OTC healthcare products for the North American market, utilizing FDA-approved facility sourcing to deliver high-quality, affordable offerings (FDA-approved)
- Diclofenac Sodium and Misoprostol: A combination medication in tablet form that delivers pain relief and helps prevent stomach ulcers, integrating both active agents (combination-tablet)
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Nivagen Pharmaceuticals
ApiJect
HQ: United States
Website
- Description: Provider of a medical technology platform enabling scalable manufacturing and fill-finish of prefilled, single-dose injectors using Blow-Fill-Seal aseptic packaging. Offers the Prefilled ApiJect Injector with a pen needle–style hub; technology licensing for BFS mold/device design, development and production support; and design and engineering services for BFS fill-finish of temperature-sensitive biologics and vaccines.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ApiJect company profile →
BioCentriq
HQ: United States
Website
- Description: Provider of cell and gene therapy development and GMP manufacturing services, including process development (upstream and downstream), clinical-grade drug product manufacturing across all trial phases, MS&T technical and regulatory support, quality assurance for cGMP compliance, workforce development training, and the LEAP Advanced Therapy Platform to accelerate transition from contract to clinic.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full BioCentriq company profile →
PCAS
HQ: France
Website
- Description: Provider of technology-oriented fine chemical development and production services, specializing in processes and complex molecule manufacturing for Life Sciences and Specialty Chemicals markets. Serving global industrial customers since 1962, with a focus on safety, reliability, and compliance with sustainable development, ISO, and GMP regulations.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full PCAS company profile →
ANMI
HQ: Belgium
Website
- Description: Provider of innovative radiopharmaceutical solutions, developing radiometals labeled theranostic radiopharmaceuticals and delivering global services in the nuclear medicine and radiopharmaceutical fields, including solutions that facilitate scalable synthesis; based in Liège, Belgium.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ANMI company profile →
Prince Sterilization
HQ: United States
Website
- Description: Provider of medical device sterilization services, offering steam sterilization to eliminate all forms of microbial life, low-temp vaporized hydrogen peroxide sterilization for heat-sensitive equipment, and dry heat sterilization for materials that withstand high temperatures.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Prince Sterilization company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Nivagen Pharmaceuticals
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Nivagen Pharmaceuticals
2.2 - Growth funds investing in similar companies to Nivagen Pharmaceuticals
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Nivagen Pharmaceuticals
4.2 - Public trading comparable groups for Nivagen Pharmaceuticals
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →